https://doi.org/10.1093/jnci/djt235
T
Thomas Keller
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
236
Papers
5.5K
Citations
41
h-index
122
i10-index
Thomas Keller is an academic researcher from Zimmer Biomet (Netherlands). The author has contributed to research in topics: Cellular Mechanics and Interactions & Forensic Toxicology and Drug Analysis & Cell Image Analysis Techniques. The author has an h-index of 41, co-authored 201 publications.
ORCID: 0000-0001-8160-3046Papers by this author
worksScreening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study
2013 · JNCI Journal of the National Cancer Institute · 222 citations
TEP versus TAPP: comparison of the perioperative outcome in 17,587 patients with a primary unilateral inguinal hernia
2015 · Surgical Endoscopy · 176 citations
https://doi.org/10.1007/s00464-015-4150-9
Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy
2016 · Breast Cancer Research · 78 citations
https://doi.org/10.1186/s13058-016-0679-3
Novel synthetic opioids – toxicological aspects and analysis
2019 · Forensic Sciences Research · 69 citations
https://doi.org/10.1080/20961790.2019.1588933
Prognostic and predictive impact of soluble epidermal growth factor receptor (sEGFR) protein in the serum of patients treated with chemotherapy for metastatic breast cancer.
2006 · PubMed · 44 citations
Bay11-7082 inhibits the disintegration of the lymphendothelial barrier triggered by MCF-7 breast cancer spheroids; the role of ICAM-1 and adhesion
2012 · British Journal of Cancer · 43 citations
https://doi.org/10.1038/bjc.2012.485
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat